“Rising Prevalence of Respiratory Infections”
One major trend driving the human metapneumovirus (HMPV) testing market growth is the rising prevalence of respiratory infections, particularly in vulnerable populations such as children, elderly, and immunocompromised individuals. This has heightened the demand for effective diagnostic solutions. HMPV, a major cause of respiratory diseases, necessitates accurate and timely detection, thus driving growth in the testing market.
Advancements in diagnostic technology, especially PCR-based tests, have greatly improved testing accuracy and speed, which boosts market demand. Additionally, the emergence of rapid diagnostic tests (RDTs) has facilitated quicker, more accessible testing, particularly in point-of-care and home healthcare settings, expanding market reach.
Increased awareness about respiratory infections, coupled with government initiatives aimed at improving healthcare infrastructure, particularly in developing regions, has further fueled market growth. North America and Asia-Pacific are seeing strong adoption of advanced diagnostic techniques, contributing to the overall market expansion.
